Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
PainChek Ltd ( (AU:PCK) ) has provided an announcement.
PainChek Ltd announced its participation in the NWR Virtual Healthcare Conference, where CEO Philip Daffas will present the company’s innovative pain assessment solutions. This participation highlights PainChek’s ongoing efforts to enhance its industry positioning and expand its market reach, particularly in home care and disability services. The company’s technology, which has been validated in clinical studies, continues to support accurate pain management for individuals with conditions affecting their ability to self-report pain, including dementia and disability.
More about PainChek Ltd
PainChek Ltd is a company in the healthcare industry, known for developing the world’s first smartphone-based pain assessment and monitoring application. Their primary product, the PainChek app, is a regulatory-cleared medical device that aids in pain management for individuals who cannot reliably self-report their pain. The app is available globally and is used in over 1,600 aged care facilities, conducting millions of digital pain assessments.
Average Trading Volume: 1,072,286
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$52.62M
Learn more about PCK stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue